PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
18-Oct-2023 TrialAssure Uses Artificial Intelligence to Create Plain Language Summaries for 50,000 Studies Listed on ClinicalTrials.Gov TrialAssure
17-Oct-2023 New publication shows XF-73 drug potent against 2,527 Staphylococcus isolates Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains Destiny Pharma
17-Oct-2023 STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics STORM Therapeutics Ltd
17-Oct-2023 Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam Abcam plc
17-Oct-2023 PATIENTS DOSED WITH METHYLONE IN LONDON IN NEW CLINICAL TRIAL TO TREAT PTSD Clerkenwell Health
17-Oct-2023 Cherwell to participate in sterile product manufacturing think tank discussions Cherwell
17-Oct-2023 AI startup Leucine nets $7M to level up Pharma manufacturing compliance to keep pace with drug innovation Leucine nets $7M to level up pharma manufacturing compliance to keep pace with drug innovation
17-Oct-2023 Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment Tilray Medical
17-Oct-2023 CD BioSciences Launches New 3D Tissue Imaging Services CD BioSciences
17-Oct-2023 HighRun DataScience Launches Data Science Platform for Global Customers HighRun DataScience
17-Oct-2023 CD BioSciences Launches New Services to Study Catabolism in Diabetes CD BioSciences
17-Oct-2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA ImmunOs Therapeutics
16-Oct-2023 Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder Teva Pharmaceuticals
13-Oct-2023 AbbVie Announces Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo as Program Advances to Phase 3 AbbVie
13-Oct-2023 Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster Phesi
13-Oct-2023 Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa UCB
12-Oct-2023 Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards CluePoints
12-Oct-2023 AlzeCure presents clinical phase II-data with ACD440 for neuropathic pain at pain conference AlzeCure
12-Oct-2023 CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research CD Bioparticles
11-Oct-2023 PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting PureTech